| Title: | BARR PHARMACEUTICALS INC-DETAILED PRODUCT PIPELINE |
| Price: | $3,440.00 |
| Publication Date: | Jun 28, 2006 |
| Source: | LIFE SCIENCE ANALYTICS |
| Brief Excerpt: | ...Barr Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and marketing of pharmaceutical products. The company operates in two segments, Generic Pharmaceuticals and Proprietary Pharmaceuticals. The Generic Pharmaceuticals segment markets approximately ### dosage forms and strengths of approximately ## different generic pharmaceutical products, including ## oral contraceptive products, representing the category of its generic portfolio. It manufactures products in the form of tablets, capsules, and powder. The Proprietary Pharmaceuticals segment markets ## proprietary pharmaceutical products, focusing in the female healthcare arena, including oral contraceptive and hormone therapy products; oncology; cardiovascular; anti -infective; and psychotherapeutic pharmaceuticals. These products include Aygestin, for amenorrhea; Cenestin line of hormone therapy products; Diamox and Sequels, for glaucoma; Loestrin/Loestrin Fe, and Nordette, for oral... |
| Length: | 87 Pages
(86 Billable Pages)
|
| Company: | BARR PHARMACEUTICALS INC |
| Geographic Regions: | MID-ATLANTIC/MIDDLE ATLANTIC REGION, NORTH AMERICA, NEW YORK (STATE OF), UNITED STATES OF AMERICA |
| Non-Billable Page Numbers: | 87 |
| Format: | 
Adobe Acrobat
|
Looking For Something Else?
